Description
In this rich dialogue between thoracic radiologist John Newell, MD, and VIDA CEO Susan Wood, PhD, the impact of AI in the midst of a global pandemic is explored. Dr. Newell and Dr. Wood discuss the evolving role of imaging for COVID-19 and the importance of a holistic, quantitative approach to managing patients with respiratory conditions. The two share COVID-19 case examples, as analyzed by VIDA’s LungPrint solution, in a demonstration of several use cases. The exchange includes a reflection on how the imaging community has excelled in responding to COVID-19, and addresses important forward-looking opportunities for ongoing respiratory health management of both recovered COVID-19 patients and patient populations with other forms of lung and airway diseases.
Highlights
Why are chest CT exams so time consuming to read?
“The lungs are a very large structure, with complex airway and vascular anatomy, along with a large number of slices to be read. A recent publication has identified chest CT are the most time-consuming of all radiology exams.”
What is the impact of comorbidities like COPD and ILD on COVID-19 patients?
“The meta-analysis of retrospective studies confirms that COPD is associated with a dramatically increased risk of aggravation in patients with COVID-19. COVID-19 patients with COPD had a 5.9-fold higher risk of progression than patients without COPD.”
Wang, B et al
There’s More!
See the complete webinar for much more, including:
- Dr. Newell’s perspective on the lasting effects of COVID-19 on lung function
- Case example of a patient with ILD and COPD
- Case example of a patient with COVID-19 and COPD
- A longitudinal case example of a patient with ILD over two timepoints
- Q&A
Speaker Bios
John Newell, MD, FACR
Cardiothoracic Radiologist
Dr. Newell has over 30 years of experience as a CardioPulmonary Diagnostic Radiologist working in clinical care, research, administration and education. He was certified in 1980 as a Diagnostic Radiologist by the American Board of Radiology. He is a Fellow of the American College of Radiology, a member of the Fleischner Society, a member of the American Association of Physicists in Medicine and member of IEEE.
Dr. Newell’s ongoing professional goals are to improve medical imaging’s ability to meet the needs of patients from all countries through improvements in the delivery of clinical imaging, research and education. He specializes in CardioThoracic Diagnostic Radiology, Biomedical Engineering, Medical Physics, and Flight Surgeon.
Susan Wood, PhD
CEO, VIDA
Dr. Wood most recently held the position of Executive Vice President of Marketing and Technology for Vital Images, an innovative advanced visualization software company. Prior to Vital Images, Dr. Wood served as VP of marketing at R2 Technology (now Hologic), where she championed the development, regulatory approval and commercial release of the first FDA approved (PMA) software product for the automatic detection of lung nodules in both diagnostic and screening chest CT examinations.
Dr. Wood received her Ph.D. from the Johns Hopkins Medical Institutions, School of Hygiene and Public Health. Her Ph.D. work combined quantifying three-dimensional lung structure with changes in lung function using high-resolution CT imaging. She also holds a Master of Science degree in Biomedical Engineering from Duke University, and a Bachelor of Science in Engineering from the University of Maryland, College Park.
Dr. Wood has been issued six patents in the field of computer-aided detection and quantitative imaging; authored numerous book chapters, peer-reviewed papers, abstracts, and served as a speaker at numerous conferences in the area of three-dimensional imaging of the thorax, quantitative imaging and computer-aided detection.